An interventional study of No exercise intervention group and Resistance band exercise intervention group in Metabolic Syndrome, Dyslipidemias and Insulin Resistance, sponsored by Pusan National University. Completed at 1 site in United States. Open to female participants. Per ClinicalTrials.gov, last updated 2020-11-03.
Sponsored by Pusan National University · Not applicable, Interventional, and Health services research
Among 579 studies in Metabolic Syndrome with a site in United States — 62 open to participants now, 84 under way, 3 of them phase 3. Metabolic Syndrome · United States.
Among the 579 studies in Metabolic Syndrome with a site in United States, this one is the 300th largest by enrollment of the 491 interventional ones that give a count, is one of 29 that started in 2018, is one of 346 with no phase, and was the 427th registered.
2,116 studies on the registry are indexed under Metabolic Syndrome; 347 are open to participants now.
Browse Metabolic Syndrome studies →62 of the 579 studies in Metabolic Syndrome with a site in United States are open now. Recruiting first, the newest first:
Arizona State University · Sites in United States
Northwell Health · Sites in United States
Longevity Metrics, Inc. · Sites in United States
University of Virginia · Sites in United States
Ann & Robert H Lurie Children's Hospital of Chicago · Sites in United States
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 232 Metabolic Syndrome studies recruiting now, 68 (29%) set no upper age limit and 136 (59%) stop at 75 or younger; 20 take children under 18; 80 take healthy volunteers.
This study: female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
579 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 35 · Phase 2 68 · Phase 3 20 · Phase 4 44
First in 1982; this study’s year is marked. 29 started in 2018.
This study's enrollment of 36 is below the median of 60 across 1,572 interventional studies indexed under Metabolic Syndrome.
Median enrollment 48 across the 491 interventional studies, 141 across the 86 observational. Of the 443 that completed or were terminated, 136 (31%) have results posted.
This tab as a report to print or save as PDF → With an account.
47 of 579 have an industry lead sponsor. The 10 most frequent:
Pusan National University is the lead sponsor of 17 studies on the registry; none are open to participants now.
Pusan National University has 1 study filed under Metabolic Syndrome — fewer than ten, so there is no comparison to draw.
28 of the studies in Metabolic Syndrome with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07625332Phase 3Northwell HealthPilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI) | 2027-08 |
| NCT07095426Ball State UniversityImpact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes | 2026-11 |
| NCT04974554Medical University of South CarolinaFIT Families Multicomponent Obesity Intervention for African American Adolescents | 2026-11-30 |
| NCT05943626University of UtahCircadian Intervention to Improve Cardiometabolic Health | 2026-12 |
| NCT05654142University of Illinois at ChicagoThe PIVOT Trial: Project on EHR-Integrated Lifestyle Interventions for Adults Aged Fifty and Older | 2026-12-31 |
Among the 579 studies in Metabolic Syndrome with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study was to examine the impacts of a 12-week resistance band exercise program on insulin resistance, blood lipid profiles, body composition, and blood pressure in postmenopausal women with obesity.
Thirty-six postmenopausal women participated in this study. Participants were randomly allocated into the resistance band training group (EX, n = 18) or the control group (CON, n = 18). The EX group performed a resistance band exercise training program 60 minutes per day, 3 times per week, for 12 weeks. The CON group did not participate in any exercise, dietary, or behavioral intervention. Blood glucose, insulin, homeostatic model of insulin resistance (HOMA-IR), blood lipids, blood pressure, and body composition were measured before and after 12 weeks of EX or CON.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Postmenopausal
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
No exercise intervention
Other: No exercise intervention group
Exercise intervention group (resistance band exercise training for 12 weeks, 3x per week, for 60 minutes per day).
Behavioral: Resistance band exercise intervention group
no exercise intervention
Resistance band exercise training intervention (12 weeks, 3x per week, for 60 minutes per day)
Glucose
Blood glucose was measured before and after 12 weeks.
Time frame: 12 weeks
Insulin
Blood insulin was measured before and after 12 weeks.
Time frame: 12 weeks
Percentage of Body Fat
Body fat percentage was measured before and after 12 weeks.
Time frame: 12 weeks
Waist circumference
Waist circumference was measured before and after 12 weeks.
Time frame: 12 weeks
Systolic blood pressure
Systolic blood pressure was measured before and after 12 weeks.
Time frame: 12 weeks
Diastolic blood pressure
Diastolic blood pressure was measured before and after 12 weeks.
Time frame: 12 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from Apr 2018 to primary completion in Aug 2018, 4 months.
Of 625 non-industry interventional studies with no phase under Metabolic Syndrome, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 41. This study's 4 months is below that.
Counting every sponsor, half of 675 studies reached it within 20 months; a quarter within 9 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pusan National University